Clinical Trials List
2022-08-25 - 2025-12-19
Phase III
Recruiting4
ICD-10B44.1
Other pulmonary aspergillosis
ICD-10B44.2
Tonsillar aspergillosis
ICD-10B44.7
Disseminated aspergillosis
ICD-10B44.89
Other forms of aspergillosis
ICD-10B44.9
Aspergillosis, unspecified
ICD-10B48.4
Penicillosis
ICD-9117.3
Aspergillosis
-
Trial Applicant
TAIWAN PSI HEALTH DEVELOPMENT COMPANY LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Chung-Hao Huang 無
- Yen-Hsu Chen 無
- Hung-Ling Huang 無
- 鄭孟軒 無
- Shang-Yi Lin 無
- 張雅婷 無
- 羅世豪 無
- Tun-Chieh Chen 無
- Ming-Ju Tsai 無
- Chun-Yuan Lee 無
- 蔡毓德 無
- Chau-Chyun Sheu 無
- Yi-Chang Liu 無
- Hui-Hua Hsiao 無
- 陳家閔 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chien-Chin Lin 無
- BANG-BIN CHEN 無
- CHAO-CHI HO CHAO-CHI HO 無
- - - 無
- 田豐銘 無
- MING YAO 無
- Huai-Hsuan Huang 無
- HSIN-AN HOU 無
- 陳抱宇 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
13 participants
-
Global
123 participants
